ClinicalTrials.gg
Drug

Neosaxitoxin clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2005

How each study uses neosaxitoxin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Neosaxitoxin
1

Studies by the year they started

3 studies that test it; most in 2005 (1)

Studies that test neosaxitoxin, by start year
YearStudies
20051
20131
20181

By phase

A phase 1/2 study counts in both.

Phase 1
3

Who runs them

Industry 1 · Other 2

Charles Berde (1) · University of Chile (1) · Grünenthal GmbH (1)

Studies

Open first, then newest update. How each study uses neosaxitoxin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Codes

What other systems call neosaxitoxin · ClinicalTrials.gg INT003038

  • MeSH (NLM) C034902neosaxitoxinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6YRL8BWD9HNEOSAXITOXINConfirmed NLM, Wikidata
  • Wikidata Q6040896neosaxitoxinConfirmed NLM, Wikidata
  • DrugBank DB12989One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.